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Abstract
Background The First International Breast (Implant) Con-
ference was held by the EAoS® (European Academy of
Senology) in cooperation with the German Society of
Senology during its 29th annual meeting in Düsseldorf,
Germany, on 13 June 2009.
Methods It was performed as a whole-day interactive
workshop in which the standards of implant surgery within
reconstructive and aesthetic breast surgery were discussed
and defined by telecommunication dialogue voting.
Results This article describes the conference results
concerning pre- and post-procedural imaging in patients
with breast implants. Both before and after augmentation,
imaging is mandatory and provides essential information
concerning tissue and implant integrity. Whereas mammog-
raphy is the first-line method before surgery, ultrasound is
the mainstay of post-procedural imaging. Cancer screening
in augmented breasts generally follows the same guidelines
as for non-augmented breasts.
Conclusion Whereas agreement about the indications for
mammographical and sonographical evaluations is largely
unanimous, there was substantial disagreement as far as the
application of magnetic resonance imaging is concerned.
There is an obvious demand for an evidence-based
evaluation of this modality and the implementation of
appropriate guidelines.
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Introduction
Breast implant insertion has evolved as a largely established
and accepted modality for reconstruction after mastectomy,
correction of congenital malformations and cosmetic
augmentation of the breast [1]. The procedural volume of
alloplastic breast implant reconstruction and augmentation
is high, and it will further increase in the future. According
to benchmark studies of the West German Breast Center
[2], the mastectomy rate in Germany is currently about 35%,
resulting in about 15,000–25,000 mastectomies per year. In
addition to this figure, there is an ever-increasing demand for
cosmetic breast implantation that has led to a dramatic rise in
procedure numbers in the past 2 decades [3, 4]. To date,
breast augmentation with single lumen silicone implants—
currently the ‘gold standard’ of augmentation—is the single
most common cosmetic procedure in the UK [5].
There are a number of issues that may require diagnostic
imaging in patients with breast implants:
& Regular screening mammography
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lesions
& Interventional biopsy
& Specific implant-related complications such as abnor-
mal immune response or connective tissue diseases [6]
and implant-associated tumors [7]
& Implant leakage or rupture [8]
Patients with breast implants present the radiologist with
specific challenges, such as the identification and distinc-
tion of implant and breast tissue, diagnosis of implant
defects and implant-related complications as well as
diagnosis and follow-up of unrelated breast diseases such
as mastitis or breast cancer [9]. The fact that an increased
mortality due to malignant disease has been described
among patients with breast implants [10] may indicate
specific diagnostic difficulties, and indeed a decreased
sensitivity of mammography in patients with silicone
implants has been described [11].
Whereas this indicates the necessity of a differential
diagnostic approach to breast imaging in patients with
implants—and quite likely a more central role for magnetic
resonance imaging—there are currently no widely accepted
guidelines. Therefore, interactive consensus decisions were
sought.
Consensus decisions of the First International Breast
(Implant) Conference 2009, Düsseldorf
The expert panel consisted of 26 invited renowned experts
from 5 countries (Germany, n=20; USA, n=2; Austria, n=
2; UK, n=1; Italy, n=1), including one of the pioneers of
breast implantology (Dr. Thomas Biggs, Houston), the
director of one of the busiest centers (Dr. Brian Kinney, Los
Angeles) and the entire European panel of senior breast
augmentation surgeons.
The consensus decisions were considered after a presen-
tation of the best available evidence on each issue, a full-
day discussion thereafter and a 2-day workshop focussing
on the topic.
Decisions were made by means of telecommunication
dialogue (TED) voting, i.e. each participant pushed the
appropriate one of three buttons on a remote control device
after a question was projected on-screen.
The conference decisions concerning imaging in patients
before implant insertion or with implants, respectively, are
displayed in Table 1.
Imaging before implant insertion
In general, a majority of attendees considered imaging
before breast implantation as a necessity [except for very
few exceptions, e.g., in very young women (<25 years)
without specific risk factors], and bidirectional mam-
mography in combination with ultrasound is the pre-
ferred modality. There are several reasons to recommend
some form of imaging before breast augmentation, with
the possibility of opportunistic cancer detection being
just one of them. The other key reasons that make
breast imaging before augmentation practically manda-
tory are
& exclusion of suspicious lesions prior to surgery and
& diagnosis and documentation of pre-existing tissue
alterations such as microcalcifications, etc.
Even if the latter are no reason for immediate further
diagnostic and/or therapeutic measures, the documentation
may be of crucial clinical—and forensic—importance if
and when malignant lesions intercurrently occur in the
augmented breast [12].
The general diagnostic properties of mammography and
ultrasound determine that both methods should be
employed in this order, just as in breast cancer screening.
Sophisticated MR imaging and CAD calculation of implant
size and shape [13] are currently uncommon; MRI is only
employed by 9%, but may become more important in the
future.
Imaging after implant breast reconstruction
following mastectomy
After mastectomy, the reconstructed breast is mostly
examined by ultrasound (90%), whereas MRI (42%) and
especially mammography (9%) are substantially less
frequently recommended. This preference is quite obvi-
ous and mainly dictated by the anatomical circumstances
after mastectomy where both MRI and mammography
are impractical because of the lack of mammary gland
tissue.
Imaging after implant breast augmentation
After breast augmentation, imaging as such was stipulated
unanimously, and there are two main and equally important
indications for this: Diagnostic workup of possible implant
rupture and ongoing breast cancer screening and diagnosis
in implant-bearing patients. In general, ultrasound and—to
a somewhat lesser extent—mammography were named as
the methods of choice. Once again, MRI played an almost
negligible role.
This opinion is well in line with the diagnostic require-
ments in patients after breast augmentation: The major
specific complication is intra- or extra-capsular implant
rupture, which occurs in up to 50% of women with
augmented breasts within 12 years [14]. Studies on newer
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about 15% within 10 years [15], but considering the high
(and increasing) number of women with implants, rupture
must be considered a frequent condition. Implant rupture
has well-defined and discernible sonographic features, i.e.
the classical “snowstorm” appearance with dense acoustic
shadowing [16]. A completely negative ultrasound exami-
nation has a very high predictive value for implant integrity
[17], limiting the application of mammography or MRI to
sonographically suspicious cases [5].
Although ultrasound diagnosis of implant failure is
basically feasible, MRI evaluation is frequently recommen-
ded [16] and may become more important in the future [9,
18]. Presently, MRI is recommended in the diagnostic
workup of clinically or sonographically suspicious cases,
but not in asymptomatic women without previous conven-
tional imaging [19], and an evidence-based assessment of
its superiority over sonography in terms of diagnostic
accuracy would be required to justify the general recom-
mendation of the substantially more expensive MRI.
The second important issue in post-implant imaging is
breast cancer screening and diagnosis. The suspected
relationship between breast implants and cancer has
essentially been disproved, but considering the high
number of women with implants, cancer diagnosis in
the augmented breast is a major issue [15, 20]. The
mainstay of tumor screening and diagnosis in the
augmented breast is—just as in non-operated patients—
mammography and ultrasound in that order [22]; however,
the sensitivity of both methods for cancer detection may
be reduced in augmented breasts [11, 21], and patients
ought to be informed of this fact before they undergo
surgery. Therefore, the re-evaluation with MRI—which is
discussed elsewhere in this paper—may become more
important in augmented breasts, but currently the literature
provides no sufficient evidence for its recommendation
[21].
Three-dimensional ultrasound may become a basis of
contemporary postoperative breast implant evaluation, thus
providing a combination of medical diagnosis and aesthetic
assessment for which so far only a few relatively
demanding methods are available [23–25]; however, there
is presently no evidence of this application of available
breast scanner systems.
Table 1 Conference decisions on imaging in breast implantology (percentage of votes)
Percentage of votes
Question ‘Yes’‘ No’‘ Rarely’
Should diagnostic imaging be performed before implant insertion without prior disease? 77 15 8
Mammography, always bidirectional 92 4 4
Mammography and mammasonography 81 15 4
Magnetic resonance (MR) mammography 8 77 15
Which diagnostic procedure do you recommend after implant reconstruction following mastectomy? Mammography? 15 85 0
Which diagnostic procedure do you recommend after implant reconstruction following mastectomy? Sonography? 92 8 0
Which diagnostic procedure do you recommend after implant reconstruction following mastectomy?
Magnetic resonance imaging (MRI)? 42 15 42
Which diagnostic procedure do you recommend after augmentation with implants?
Mammography? 77 15 8
Which diagnostic procedure do you recommend after augmentation with implants?
Sonography? 92 8 0
Which diagnostic procedure do you recommend after augmentation with implants?
MRI? 42 7 6 9
Can interventional biopsies be performed on implant patients? 85 0 15
How would you perform a biopsy? Always open? 12 62 27
Do you perform breast MRI after implant insertion in case of leakage without contrast medium? 42 50 8
Is MRI critical for differential diagnosis of focal diagnostic findings after implant insertion? 62 27 12
…Upon leakage suspicion with contrast media? 54 46 0
…Upon leakage suspicion without contrast media? 38 62 0
…Upon tumor suspicion? 81 19 0
…In the case of palpation findings when sonography
and mammography are without pathological findings? 46 54 0
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A substantial majority considered interventional biopsies in
the augmented breast basically feasible and would only
occasionally and upon necessity resort to open procedures.
Since implants present very well on sonography and other
imaging modalities, a decline in the number of interven-
tional biopsies would hardly be justified. However, an
interventional core needle biopsy has to be performed with
particular care in order to avoid iatrogenic implant rupture
[22].
Application of MRI after implant insertion
The value of MRI after breast augmentation is the one issue
of substantial controversy. Almost regardless of the
respective application, the number of votes for and against
MRI in the panel discussion were equal. The only situation
where most participants agreed about MRI making sense
was a suspicion of tumor in the augmented breast, and this
view is in accordance with the literature [e.g., 9, 18, 19,
26]. However, MRI is currently considered to be a second-
line method to be applied after mammography has yielded a
suspicious result that could not be verified or falsified by
ultrasound examination or in cases of peri-implant positiv-
ity at clinical examination with inconclusive results of
conventional imaging [19, 22]. The same applies to the
diagnosis of implant rupture where the value of MRI is
undeniable, but its application limited to cases with
inconclusive results of conventional imaging [5, 9, 26,
27]. Presently, the literature provides no evidence for the
recommendation of MRI for screening purposes in patients
with augmented breasts as given by the US Food and Drug
Administration [28].
Conclusions
1. Before breast augmentation, imaging is strongly rec-
ommended for most women. It will mainly follow the
same guidelines as in routine mammography screening,
i.e. mammography followed by ultrasound if necessary.
Findings that don’t require immediate diagnostic or
therapeutic action should be thoroughly documented.
2. Following augmentation after mastectomy, imaging is
also a necessity, but ultrasound is the method of choice
due to morphological and practical considerations.
3. The follow-up of previously healthy augmented breasts
is guided by two rationales: diagnosis of complications
(i.e., mainly rupture) and cancer screening. For the
former, ultrasound examination is the current method of
choice, whereas cancer screening in augmented breasts
requires mammography.
4. Interventional biopsies in augmented breasts can and
should be performed under more or less the same
guidelines as in non-augmented breasts.
5. The role of MRI in the evaluation of breast implant-
bearing patients is possibly emerging, but presently
controversial. Controlled trials with high methodolog-
ical standards will be required to better define its
specific values and to implement evidence-based guide-
lines; however, sonography and mammography still
provide a very satisfactory basis.
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